Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-034784
Filing Date
2025-04-14
Accepted
2025-04-14 18:57:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 16910
2 EXHIBIT 99.1 tm2512303d1_ex99-1.htm EX-99.1 8721
  Complete submission text file 0001104659-25-034784.txt   27381
Mailing Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131
Business Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131 305-929-6851
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Subject) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88701 | Film No.: 25837133
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)